The Human Genome and Sport, Including Epigenetics, Gene Doping, and Athleticogenomics

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 1, 2010, Pages 201-215

  Sharp, N C Craig ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Athleticogenomics; Epigenetics; Gene doping; Genome sport

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; APOLIPOPROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; APOLIPOPROTEIN C; APOLIPOPROTEIN E; DNA; ERYTHROPOIETIN RECEPTOR; LIPOSOME; MESSENGER RNA; MYOSTATIN; PARVOVIRUS VECTOR; RETROVIRUS VECTOR; SOMATOMEDIN C; VASCULOTROPIN;

ATHLETICOGENOMICS; CHROMOSOME ANALYSIS; CHRONIC FATIGUE SYNDROME; DOPING; ENDURANCE SPORT; EPIGENETICS; GENDER; GENE SILENCING; GENE THERAPY; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; HUMAN GENOME; INTRON; NONHUMAN; PRIORITY JOURNAL; RETROPOSON; REVIEW; RISK ASSESSMENT; RNA INTERFERENCE; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSPOSON;

ANIMALS; APOLIPOPROTEINS E; DOPING IN SPORTS; EPIGENESIS, GENETIC; ERYTHROPOIETIN; FATIGUE; FATIGUE SYNDROME, CHRONIC; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MYOSTATIN; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, ERYTHROPOIETIN; SEX DETERMINATION (ANALYSIS); SPORTS;

EID: 74049110455     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2009.10.010     Document Type: Review

References (56)

1. Dunlap K.A., Palmarini M., Vareia M., et al. Endogeneous retrovirus regulates peri-implantation, placental growth and differentiation. Proc Natl Acad Sci 103 39 (2006) 14390-14395
2. Waterland R.A., and Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23 15 (2003) 5293-5300
3. Riggs A.D., and Porter T.N. In: Russo V.E.A., Martienssen R.A., and Riggs A.D. (Eds). Epigenetics: mechanism of gene regulation (1996), Cold Spring Harbor Laboratory Press, Woodbury (NY) 34-53
4. Doliny D.C., Weidman J.R., Waterland R.A., et al. Maternal genisten alters coat colour and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114 4 (2006) 567-572
5. Waterland R.A., Travisano M., and Tahiliani K.G. Diet-induced hypermethylation at agouti viable yellow is not inherited transgenerationally through the female. FASEB J 21 (2007) 3380-3385
6. Pando O.J., and Verstrepan K.J. Epigenetic switches. Cell 128 4 (2007) 655-668
7. Ecclestone A., DeWitt N., Gunter C., et al. Epigenetics; nature insight. Nature 447 (2007) 395-440
8. Lyon M. How X-chromosome inactivation was discovered. Biologist 54 2 (2007) 94-97
9. Jordan B.D. Chronic traumatic brain injury associated with boxing. Semin Neurol 20 2 (2000) 179-185
10. Jordan B.D., Relkin N.R., and Ravdin L.D. Apolipoprotein E4 associated with chronic traumatic brain injury in boxing. JAMA 278 2 (1997) 136-140
11. Loosemore M., Knowles C.H., and Whyte G.P. Amateur boxing and risk of chronic traumatic brain injury: systematic review of observational studies. BMJ 335 (2007) 809-819
12. Budgett R., Newsholme E.A., Sharp N.C.C., et al. Redefining the overtraining syndrome as the unexplained underperformance syndrome. Br J Sports Med 34 (2000) 67-68
13. Hooper R. Chronic fatigue syndrome. New Sci 187 2509 (2005) 9-11
14. Kaushik N., Fear D., Richards S.C., et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 58 (2005) 826-832
15. Puri B.K. Long chain fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome). J Clin Pathol 60 (2007) 122-124
16. Lavitrano M. Pig lets vector stay. Proc Natl Acad Sci 103 (2006) 17672-17677
17. Culver K., Anderson F., and Blaese R. Lymphocyte gene therapy. Hum Gene Ther 2 (1991) 107-109
18. Nakamura T. Marfan's syndrome: a mutation in the fibrillin-1 gene. Nature 415 (2002) 168-171
19. Kodadek T. Turning up genes. 'Research highlights'. Nature 446 (2007) 472
20. Wagner R., and Sun L. Functional genomics: double-stranded RNA poses puzzle. Nature 391 (1990) 744-745 (Fire and Gallo ref)
21. Abbott A. Youthful duo snag a swift Nobel for RNA control of genes. Nature 433 (2006) 488
22. Sharp N.C.C. Drugs wipe out a sporting chance. Nature 398 (1999) 675
23. Montgomery H.E., Marshall R., Rayson M., et al. Human gene for physical performance. Nature 393 (1998) 221-222
24. Yang N., MacArthur D.G., Hahn A.G., et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 73 3 (2003) 627-631
25. Bray M.S., Hagberry J.M., Rankinen T., et al. The human gene map for performance and health related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc 41 1 (2009) 35-73
26. Sweeney H.L. Gene doping. Sci Am 291 (2004) 36-43
27. Sharp N.C.C. Doping, a misuse of science. Phys Soc Physiology News 57 (2004) 15-16
28. Shadan S. Run, whippet, run. MSTN gene and racing performance. Nature 447 (2007) 275
29. Mosher D., Quignon P., Sutter N.B., et al. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet 3 5 (2007) e79. Available at: Genetics.plosjournals.org
30. Shuelke M., Wagner K.R., Stolz L.E., et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350 26 (2004) 2682-2688
31. Elemans C.P.H., Spiers I.L.Y., Muller U.K., et al. Superfast muscles control dove's trill. Nature 431 (2004) 146
32. de la Chapelle A., Traskelin A.-L., and Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci 90 (1993) 4495-4499
33. de la Chapelle A., Sistonen P., Lehvaslaiho H., et al. Familial erythrocytosis genetically linked to erythropoietin receptor gene. Lancet 341 (1993) 82-84
34. Slot O. Raising the bar in the cheating stakes (2006), The Times, London
35. Baumgartner I., Pieczek A., and Manor O. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development on patients with critical limb ischemia. Circulation 97 (1998) 1114-1123
36. Weiss A., McDonough D., Wertman B., et al. Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. Proc Natl Acad Sci 96 (1999) 2958-2963
37. Kim T.H., Barerra L.O., and Zheng M. A high-resolution map of active promoters in the human genome. Nature 436 (2005) 876-878
38. Alexander R. The human machine (1992), Natural History Museum, London p. 74-9
39. Cox J.C., Reimann F., Nicholas A.K., et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444 (2006) 9-11
40. BBC. Available at:. http://news.bbc.co.uk/1/hi/health/4195437.stm Accessed March 2009
41. Noakes T.D., St. Clair G.A., and Lambert E.V. From catastrophe to complexity: a novel model of integrative central neural regulation of effort and fatigue during exercise in humans. Br J Sports Med 38 (2004) 511-514
42. Sharp N.C.C. The human genome and sport including epigenetics and athleticogenomics. J Sports Sci 26 11 (2008) 1127-1133
43. Sharp N.C.C. Introduction. In: Pitsiladis Y., Bale J., Sharp N.C.C., et al. (Eds). East African running: towards a cross-disciplinary perspective (2007), Routledge, Abingdon (UK) 1-7
44. Sharp N.C.C. Athleticogenomics. Peak Performance 230 (2006) 8-11
45. Collins A., Hill L.E., Reul M., et al. Exercise improves cognitive responses to psychological stress through enhancement of epigenetic mechanisms and gene expression in the dentate gyrus. PLoS One 4 1 (2009) e4330
46. Brenner S., and Roberts R. Genome sequencing. Nature 446 (2007) 275
47. Check E. Sequencing revolution ushers in new era. Nature 448 (2007) 9-11
48. Parisotto R. It's in the genes. Blood sports; the inside dope on drugs in sport (2006), Hardie Grant Books, Victoria (Australia) p. 207-22
49. MacArthur D.G., and North K.N. A gene for speed? The evolution and function of alpha-actinin-3. Bioessays 26 7 (2004) 786-795
50. Santiago C., Gonzalez-Freire M., Serratosa L., et al. ACTN3 genotype in professional soccer players. Br J Sports Med 42 (2008) 71-73
51. Ridley M. The genome (2000), 4th Estate, London
52. Spurway N. Top-down studies of the genetic contribution to the differences in physical capacity. In: Spurway N., and Wackerhage H. (Eds). Introduction to molecular exercise physiology; genetics and molecular biology of muscle adaptation (2006), Churchill Livingstone, Edinburgh (UK) 61-120 and 121-64
53. MacArthur D.G., and North K.N. Genes and human elite performance. In: Pitsiladis Y., Bale J., Sharp N.C.C., et al. (Eds). East African running: towards a cross-disciplinary perspective (2007), Routledge, Abingdon (Oxon) 217-233
54. Miah A. Genetically modified athletes: biomedical ethics, gene doping and sport (2004), Routledge, Abingdon (Oxon), and New York
55. Tamburrine C., and Tannsjo T. Genetic technology and sport: ethical questions (2005), Routledge, Abingdon (Oxon), and New York
56. Wackerhage H., Miah A., Montgomery H.E., et al. Genetic research and testing in sport and exercise science: a review of the issues. J Sport Sci 27 11 (2009) 1109-1116